Abstract
Actually, the main motivation for the contents of this chapter is to introduce fractional calculus as a prospective mathematical tool for cancer dynamics, in particular prostate cancer modeling. In this context, firstly, our main problem on the controversial role of androgens for prostate cancer development is handled, and according to our hypothesis a new mathematical model consisting of conventional logistic growth phenomena is constructed versus another prospective model based on ecological phenomena, cell quota. Then, we compare these two models demonstrating the mean squared error (MSE) values for androgen and prostate-specific antigen (PSA) for the first 1.5 cycles of intermittent androgen suppression (IAS) therapy administered to 62 selected patients from Vancouver Prostate Center (Vancouver, BC, Canada). To reduce MSE values, we also generate the fractional version of the model and verify that fractional differentiation provides nearly better data fitting for mathematical modeling. Moreover, with a discussion part, which hints for future works should be taken into account are pointed out.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
W. Deng, C. Li, Analysis of fractional differential equations with multi- orders. Fractals 15(2), 173–182 (2007)
Y. Ding, H. Ye, A fractional-order differential equation model of HIV infection of CD4 + T-Cells. Math. Comput. Model. 50, 386–392 (2009)
W. Lin, Global existence theory and chaos control of fractional differential equations. J. Math. Anal. Appl. 332, 709–726 (2007)
Z.M. Odibat, N.T. Shawagfeh, Generalized Taylors formula. Appl. Math. Comput. 186, 286–293 (2007)
O.O. Mizrak, N. Ozalp, Fractional analog of a chemical system inspired by Braess’ paradox. Comp. Appl. Math. 37, 2503–2518 (2018). https://doi.org/10.1007/s40314017-0462-9
R. Garrappa, Numerical solution of fractional differential equations: A survey and a software tutorial. Mathematics 6, 16 (2018). https://doi.org/10.3390/math6020016
S.R. Denmeade, J.T. Isaacs, A history of prostate cancer treatment. Nat. Rev. Cancer 2(5), 389–396 (2002)
N. Bruchovsky, L. Klotz, J. Crook, S. Malone, C. Ludgate, W.J. Morris, M.E. Gleave, S.L. Goldenberg, Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: Clinical parameters. Cancer 107(2), 389–395 (2006)
T. Nishiyama, Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature. Urol. Oncol. 32(1), 38–e17–28 (2013)
J.M. Crook, C.J. O’Callaghan, G. Duncan, D.P. Dearnaley, C.S. Higano, E.M. Horwitz, E. Frymire, S. Malone, J. Chin, A. Nabid, P. Warde, T. Corbett, S. Angyal, S.L. Goldenberg, M.K. Gospodarowicz, F. Saad, J.P. Logue, E. Hall, P.F. Schellhammer, K. Ding, L. Klotz, Intermittent androgen suppression for rising PSA level after radiotherapy. N. Engl. J. Med. 367(10), 895–903 (2012)
A.H. Bryce, E.S. Antonarakis, Androgen receptor splice variant 7 in castration resistant prostate cancer: Clinical considerations. Int. J. Urol. 23(8), 646–653 (2016)
B. Feldman, D. Feldman, The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1(1), 34–45 (2001)
P.C. Deaths, Cancer Statistics, 2011 The impact of eliminating socioeconomic and racial disparities on premature cancer deaths (2011)
T.L. Jackson, A mathematical model of prostate tumor growth and androgen-independent relapse. Discret. Contin. Dyn. Syst.-Ser. B 4, 187–202 (2004)
A.M. Ideta, G. Tanaka, T. Takeuchi, K. Aihara, A mathematical model of intermittent androgen suppression for prostate cancer. J. Nonlinear Sci. 18, 593–614 (2008)
T. Shimada, K. Aihara, A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer. Math. Biosci. 214, 134–139 (2008)
S.E. Eikenberry, J.D. Nagy, Y. Kuang, The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model. Biol. Direct 5, 24 (2010)
T. Portz, Y. Kuang, J.D. Nagy, A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy. AIP Adv. 2, 011002 (2012)
J. Baez, Y. Kuang, Mathematical models of androgen resistance in prostate cancer patients under intermittent androgen suppression therapy. Appl. Sci. 6, 352 (2016). doi: 10.3390/app6110352
T. Portz, Y. Kuang, J. Nagy, A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy. AIP Adv. 2, 1–14 (2012)
Y. Kuang, J.D. Nagy, S.E. Eikenberry, in Introduction to Mathematical Oncology (Chapman and Hall/CRC Mathematical and Computational Biology, 2016)
M. Droop, Some thoughts on nutrient limitation in algae1. J. Phycol. 9(264), 272 (1973)
E.M. Rutter, Y. Kuang, Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer. DCDS-B 22, 1001–1021 (2017)
N. Bruchovsky, L. Klotz, J. Crook, S. Malone, C. Ludgate, W.J. Morris, M.E. Gleave, S.L. Goldenberg, Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer. Cancer 107, 389–395 (2006)
N. Bruchovsky, Clinical Research. 2006. Available online: http://www.nicholasbruchovsky.com/clinicalResearch.html. Accessed on 18 July 2018
H. Vardhan Jain, A. Friedman, Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy. Discret. Contin. Dyn. Syst.-Ser. B. 18
Y. Hirata, N. Bruchovsky, K. Aihara, Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer. J. Theor. Biol. 264, 517–527 (2010)
Q. Guo, Z. Lu, Y. Hirata, K. Aihara, Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer. Chaos 23(4), 43125 (2013)
Y. Tao, Q. Guo, K. Aihara, A partial deferential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy. J. Math. Biol. 1–22 (2013)
Y. Hirata, K. Akakura, C.S. Higano, N. Bruchovsky, K. Aihara, Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression. J. Mol. Cell Biol. 4(3), 127–132 (2012)
Y. Hirata, S.-I. Azuma, K. Aihara, Model predictive control for optimally scheduling intermittent androgen suppression of prostate cancer. Methods 67(3), 278–281 (2014)
Acknowledgements:
O.O.M. is supported by the Scientific and Research Council of Turkey within the context of 2214-A-Ph.D. Research Fellowship Abroad and by the Scientific Research Unit of Ankara University with the grant number 17L0430006. We are also grateful to Nicholas Bruchovsky for the clinical data set.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mizrak, O.O., Mizrak, C., Kashkynbayev, A., Kuang, Y. (2020). The Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy. In: Dutta, H. (eds) Mathematical Modelling in Health, Social and Applied Sciences. Forum for Interdisciplinary Mathematics. Springer, Singapore. https://doi.org/10.1007/978-981-15-2286-4_5
Download citation
DOI: https://doi.org/10.1007/978-981-15-2286-4_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2285-7
Online ISBN: 978-981-15-2286-4
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)